Canopy Growth Corporation

Canopy Growth Corporation 8.00% stock opened at $24.00 and closed at $30.00, with intraday prices ranging from $24.00 to $30.05. The TSX Composite closed at 22673.52, up 0.57%, while the S&P 500, Dow Jones Industrial Average, and Nasdaq Composite closed up 0.55%, 0.62%, and 0.63% respectively. Canopy Growth Corporation 8.00% traded under WEED-DB on the TSX, with trading volume of 1,075 on 3 trades. The stock has traded as high as $50.00 and as low as $24.00 in the past 52 weeks, shrinking -40.00% during that period.

Canopy Growth launches Claybourne's Frosted Flyers Infused Pre-Rolls in Canada, offering five distinct flavors: Blue Dream, Strawberry Cough, Pineapple Express, Grape Gasolina, and Banana OG.

Canopy Growth reports Q2 FY2025 financial results: Storz & Bickel revenue up 32%, medical cannabis revenue up 16% in Canada and 12% internationally, balance sheet improved with $100MM prepayment on senior secured term loan. CEO David Klein highlights strong growth across key businesses and optimism for Canopy USA. CFO Judy Hong notes progress towards profitability driven by gross margin improvement and SG&A expense reduction.

Oxford Cannabinoid Technologies (OCT) announces successful completion of AI-enabled drug discovery asset, developed with Hypatia AI, to accelerate research on cannabinoid-based pain medications, reducing reliance on opioids.

Canopy Growth Corporation (CGC) is a leading North American cannabis company with a diverse portfolio of brands and significant presence in medicinal and recreational markets. Recent developments include new pre-roll products, financial stability enhancements, and strategic acquisitions in the U.S. market. The company also focuses on social equity and responsible use.